Cleanspace Holdings Ltd (csx) Logo

Cleanspace Holdings Ltd (CSX)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CSX Chart

Snapshot

CSX's Principal Activity is the design, manufacture and production of respiratory protection equipment used in the industrial and healthcare sectors.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -79.26%
vs ASX 200 (1yr) -97.55%

Size

Market Capitalisation
ASX Rank 949 of 2,319
Sector Rank 81 of 198

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies DOC / AT1 / BNO
EPS $0.154
DPS $0.00
NTA per share $0.53

Broker Consensus

Breakdown 0 Buy · 4 Hold · 4 Sell
Recommendation Sell
Last Updated 04/10/21

Announcements

Date Heading Pages File Size Time

Corporate Overview

CleanSpace Holdings Limited (CSX) designs, manufactures and sells workplace respiratory protection equipment (RPE) for healthcare and industrial end markets. PAPRs are specialised respirators that come equipped with blowers, filters, respirator hood or face-pieces, and breathing tube assemblies. CleanSpace's PAPRs are designed for two markets: Healthcare and Industrial.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office St Leonards NSW 2065
Website www.cleanspacetechnology.com
Registry BoardRoom
Auditor PKF(NS) Audit & Assurance Limited
Date Listed 23 Oct 2020

Upcoming Calendar (Forecasted)

Date Event
24/02/2022 Report (Interim)
26/08/2022 Report (Prelim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Bruce Rathie Chair elect,Non-Executive Director Oct 2021 Director Bio icon

Mr Bruce Rathie

Chair elect,Non-Executive Director

Mr Rathie has more than 20 years of governance experience across a range of industries and businesses, including financial services, technology and biotechnology. Mr Rathie is currently Chair of 4DMedical Limited (ASX: 4DX) and Non-Executive Director of Cettire Limited (ASX: CTT) and PolyNovo Limited (ASX: PNV). He also has experience in law and investment banking.

Ms Elizabeth Harvey Chief Financial Officer,Joint Company Secretary Nov 2020
Ms Elissa Hansen Joint Company Secretary Nov 2020
Dr Ronald (Ron) Peter Weinberger Non-Executive Director Jul 2018 Director Bio icon

Dr Ronald (Ron) Peter Weinberger

Non-Executive Director

Dr Weinberger has over 20 years' experience commercialising medical devices. Dr Weinberger is the former Executive Director and Chief Executive Officer of Nanosonics (ASX:NAN) where he co-developed Nanosonics' platform technology. He has been Chief Executive Officer of EMVision Ltd (ASX:EMV) since December 2018 and managing director from May 2020. Dr Weinberger has also been a non-executive director and the chairperson of HeraMED Ltd (ASX:HMD) since August 2018. Dr Weinberger will be a member of the Risk Management Committee.

Mr William James Highland Non-Executive Director Aug 2015 Director Bio icon

Mr William James Highland

Non-Executive Director

Mr Highland was a senior executive and investment manager with 30 years' senior management experience in developing and building companies in Australia, USA, Asia and Europe whilst working with OPSM Protector, BTR Nylex, Boral and CVC Limited. Mr Highland has experience in the production and marketing of respiratory systems for industrial workplaces; resuscitation products for the first response markets; emergency life support systems for the mining and oil and gas markets, and breathing apparatus for the fire and rescue services. Additionally, Mr Highland has served as a director and chief executive officer for The Environmental Group Limited and as a director for SMC Gold Limited and Blue Energy Limited, which are both ASX listed companies, and also as a director and chairman of private companies, and joint venture boards. Mr Highland was Chairperson of the Board of CSX from November 2016 until December 2019. Mr Highland will be a member of the Risk Management Committee.

Dr Alexandra Margaret Birrell Chief Executive Officer,Executive Director Aug 2015 Director Bio icon

Dr Alexandra Margaret Birrell

Chief Executive Officer,Executive Director

Dr Birrell has worked in senior management roles in the healthcare and technology sector for over 20 years. Her previous roles include PricewaterhouseCoopers where she worked in the healthcare advisory practice and financial services (Technology); and Royal Prince Alfred Hospital. Dr Birrell was a member of the Board of Trustees of Museum of Applied Arts & Sciences, NSW from 2016 - 2019. Dr Birrell is a previous winner of AFR Women of Influence Awards, Chief Executive Women Scholarship.

Mr Dan Kao Director-Operations & Founder,Executive Director Apr 2011 Director Bio icon

Mr Dan Kao

Director-Operations & Founder,Executive Director

Mr Kao worked in the medical and healthcare industry for over 20 years, and has experience in manufacturing, supply chain optimisation, quality management systems and in securing patents for innovative technologies in healthcare. Mr Kao is a former senior designer for ResMed Inc (Australia) (ASX:RMD). Mr Kao is a previous winner of the Australian Design Award.

Mr Craig Stainton Lawn Non-Executive Director Apr 2011 Director Bio icon

Mr Craig Stainton Lawn

Non-Executive Director

Mr Lawn was a partner for PricewaterhouseCoopers for over 20 years, where he provided income tax and commercial advice to a various businesses, including biotechnology, venture capital and research based organisations. Further, between January 2017 and December 2019, Mr Lawn was a Non-Executive Director of Tubi Limited which listed on 14 June 2019 (ASX:2BE). In addition to CleanSpace, Mr Lawn is currently on the boards of Key Assets Pty Ltd as the Chairperson and The Red Room Company Ltd as treasurer. Mr Lawn is also a consultant advisor through Good Foundations Pty Ltd and Lawn Corporate Advisory, providing business and strategic advice to charities, private company groups, public bodies and not for profit organisations. Mr Lawn will be Chairman Risk Management Committee.

Director Transactions

CSX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
15/04/21 Ronald (Ron) Weinberger Buy +24,200 $2.061 $49,869 On-market trade

Director Interests

The current holdings of CSX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Bruce Rathie 18/10/2021 0 N/A N/A N/A
Ronald (Ron) Weinberger 15/04/2021 74,654 N/A 113,207 N/A
Alexandra Birrell 10/08/2015 N/A 2,798,962 220,470 N/A
William Highland 10/08/2015 128,915 N/A 113,207 N/A
Craig Lawn 02/03/2015 N/A 1,001,871 113,207 N/A
Dan Kao 01/04/2011 2,530,000 N/A 68,418 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Oct 21, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Walsh And Company Investments Limited ( CVC Emerging Companies A/C) 10,007,535 12.99%
National Nominees Limited 5,486,723 7.12%
Group - Bnp Paribas Noms (NZ) Ltd (Drp) 4,605,855 5.98%
HSBC Custody Nominees (Australia) Limited 4,353,203 5.65%
Chatswood Wealth Management Pty Ltd 3,850,000 5.00%
Alex Birrell (Baf A/C) 2,798,962 3.63%
Dan Kao 2,530,000 3.29%
J P Morgan Nominees Australia Pty Limited 2,199,442 2.86%
Min Fang 2,057,248 2.67%
Acorn Capital Private 1,965,166 2.55%
Paftec Investment Fund Pty Ltd (Paftec Unit A/C) 1,940,937 2.52%
Alfred H H Myers (Lucy's A/C) 1,449,481 1.88%
Linda Ying Wang (Kao And Wang Family A/C) 1,202,816 1.56%
CS Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C) 1,187,137 1.54%
Craig Lawn & Joy Lawn (Lawn Family Super Fund A/C) 1,001,871 1.30%
Peter Anthony Vogliotti 1,000,000 1.30%
Ching Ming Liu 992,242 1.29%
Washington H Soul Pattinson & Company Limited 986,394 1.28%
HSBC Custody Nominees (Australia) Limited - A/C 2 961,490 1.25%
Clement Patrick Doherty & Jayne Maree Doherty (Doherty Super Fund A/C) 850,000 1.10%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

No Substantial Shareholders for CSX in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
12-05-21 National Nominees Ltd 4,342,070 -- 5.64

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
CSX Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.